Overview

Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Status:
Recruiting

Trial end date:
2025-04-30

Target enrollment:

Participant gender:

Summary

An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel

Phase:

Phase 3

Details

Lead Sponsor:

Vanda Pharmaceuticals